A major discovery in cancer study is occurring with the use of mini-antibodies to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in several kinds of malignancies, leading https://webookmarks.com/story7623256/nanobodies-reactivate-the-p53-protein-a-new-pathway-for-tumor-treatment